The use of CD47-modified biomaterials to mitigate the immune response

Poly(3,4-ethylenedioxythiophene) Bearing Phosphorylcholine Groups for Metal-Free, Antibody-Free, and Low-Impedance Biosensors Specific for C-Reactive Protein

(2015) Tatsuro Goda et al.   ACS Applied Materials & Interfaces

Development and functional evaluation of biomimetic silicone surfaces with hierarchical micro/nano-topographical features demonstrates favourable in vitro foreign body response of breast-derived fibroblasts

(2015) Daniel J.T. Kyle et al.   BIOMATERIALS

Microfabricated microporous membranes reduce the host immune response and prolong the functional lifetime of a closed-loop insulin delivery implant in a type 1 diabetic rat model

(2015) Jason Li et al.   BIOMATERIALS

CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells

(2015) H. Bruns et al.   CLINICAL CANCER RESEARCH

Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals

(2015) M. N. McCracken et al.   CLINICAL CANCER RESEARCH

Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors

(2014) Joshua Slee et al.   Polymers

Impact of 3-D printed PLA- and chitosan-based scaffolds on human monocyte/macrophage responses: Unraveling the effect of 3-D structures on inflammation

(2013) Catarina R. Almeida et al.   Acta Biomaterialia

Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes

(2013) Weiwei Gao et al.   ADVANCED MATERIALS

Intracellular signaling mechanisms associated with CD47 modified surfaces

(2013) Matthew J. Finley et al.   BIOMATERIALS

Inflammatory Mechanisms of Adverse Reactions to BMS

(2013) Konstantinos Toutouzas et al.   Current Vascular Pharmacology

‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach

(2013) Che-Ming J. Hu et al.   Nanoscale

Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies

(2013) Che-Ming J. Hu et al.   Nanoscale

Zwitterionic hydrogels implanted in mice resist the foreign-body reaction

(2013) Lei Zhang et al.   NATURE BIOTECHNOLOGY

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

(2013) P. L. Rodriguez et al.   SCIENCE

Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces

(2012) Matthew J. Finley et al.   BIOMATERIALS

Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells

(2012) D Kim et al.   LEUKEMIA

Zwitterionic Chitosan Derivative, a New Biocompatible Pharmaceutical Excipient, Prevents Endotoxin-Mediated Cytokine Release

(2012) Gaurav Bajaj et al.   PLoS One

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

(2012) B. Edris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation

(2011) Stanley J. Stachelek et al.   BIOMATERIALS

Signal Regulatory Protein   Regulates the Homeostasis of T Lymphocytes in the Spleen

(2011) M. Sato-Hashimoto et al.   JOURNAL OF IMMUNOLOGY

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

(2011) C.-M. J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biocompatibility of implants: lymphocyte/macrophage interactions

(2011) James M. Anderson et al.   Seminars in Immunopathology

Thrombospondin-1 Is a Plasmatic Marker of Peripheral Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic Properties

(2010) David M. Smadja et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

CD47-dependent molecular mechanisms of blood outgrowth endothelial cell attachment on cholesterol-modified polyurethane

(2010) Masako Ueda et al.   BIOMATERIALS

Regulation by SIRP  of dendritic cell homeostasis in lymphoid tissues

(2010) Y. Saito et al.   BLOOD

Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels

(2010) Richard K. Tsai et al.   BLOOD CELLS MOLECULES AND DISEASES

Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia

(2010) Mark P. Chao et al.   CANCER RESEARCH

Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects

(2010) Jin-Wook Yoo et al.   CURRENT PHARMACEUTICAL DESIGN

Anaphylaxis During Cardiac Surgery: Implications for Clinicians

(2009) Jerrold H. Levy et al.   ANESTHESIA AND ANALGESIA

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

(2009) Siddhartha Jaiswal et al.   CELL

The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms

(2009) Anne Jäkel et al.   IMMUNOBIOLOGY

Understanding the inflammatory response to cardiac surgery

(2009) J. McGuinness et al.   SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

Surfactant Proteins A and D Suppress Alveolar Macrophage Phagocytosis via Interaction with SIRPα

(2008) William J. Janssen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

CD47

(2008) Jeff S. Isenberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells

(2008) Richard K. Tsai et al.   JOURNAL OF CELL BIOLOGY

Foreign body reaction to biomaterials

(2008) James M. Anderson et al.   SEMINARS IN IMMUNOLOGY

Innate immune ‘self’ recognition: a role for CD47–SIRPα interactions in hematopoietic stem cell transplantation

(2008) Timo K. van den Berg et al.   TRENDS IN IMMUNOLOGY